Table: begin end state 1 18 cytoplasmic 19 21 non-cytoplasmic 22 39 transmembrane 40 55 non-cytoplasmic 56 81 transmembrane 82 90 cytoplasmic 91 112 transmembrane 113 113 non-cytoplasmic 114 114 transmembrane 115 119 non-cytoplasmic 120 144 transmembrane 145 155 cytoplasmic 156 178 transmembrane 179 189 non-cytoplasmic 190 209 transmembrane 210 235 cytoplasmic 236 259 transmembrane 260 278 non-cytoplasmic 279 297 transmembrane 298 307 cytoplasmic 308 329 transmembrane 330 340 non-cytoplasmic 341 361 transmembrane 362 371 cytoplasmic 372 394 transmembrane 395 399 non-cytoplasmic 400 421 transmembrane 422 433 cytoplasmic
Input: >H281DRAFT_03948 FitnessBrowser__Burk376:H281DRAFT_03948 MSTASHAISSSQESKAKTVFRVVSGNFLEMYDFMVYGYYASAIAKTYFPSGSEFASLMLS LSVFGAGFLMRPLGAIVLGAYIDHHGRRKGLILTLGLMALGTLTVASIPGYATIGLLAPV LVLLGRLLQGFSAGVELGGVSVYLSEIATKGNKGFYCAWQSGSQQVAVVFAALLGVMLNK MLPADQMSAWGWRVPFLIGCLIVPFLFMIRRSLKETEEFSARKHRPGMGEIMKTMAANWG TVLGGMGMVIMTTVSFYMITAYTPTFGKEVLKLSSIDTLVVTVCIGLSNLIWLPLAGALS DRIGRRPVLLAFTALTIVTAYPALQWLVAEPSFARLLAVELWLSFLYGSYNGAMVVALTE VMPVEVRTAGFSLAYSLATTIGGFTPAISTLLIHSTGNKAAPGLFLGVAAICGLIATLVL YRTPESRDQYKAA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server